Solar Capital, which directly sources and underwrites cash flow loans, asset-based loans, life science loans and equipment financing, acquired a majority stake in Kingsbridge Holdings, which is an independent lessor of equipment based in Illinois.
Solar Capital provided $65 million in term loans for GenMark Diagnostics, a provider of multiplex molecular diagnostic solutions designed to enhance patient care, improve key quality metrics and reduce the total cost-of-care.
Solar Capital Partners provided a $75 million term loan through a loan and security agreement with Rubius Therapeutics, a biotechnology company developing a new class of allogeneic cellular therapies.
Solar Capital’s board of directors approved the reduction in the asset coverage requirement under of the Investment Company Act of 1940 as allowed under the Small Business Credit Availability Act.
Restoration Robotics reached an agreement with Solar Capital and the Life Sciences Group at Bridge Bank to secure a $20 million debt facility.
aTyr Pharma entered into a $20 million credit facility with Silicon Valley Bank and Solar Capital. aTyr intends to use the additional capital to pay off existing indebtedness and for general corporate purposes.
Solar Capital entered into an amendment to its senior secured credit agreement increasing the amount to $555 million from $540 million. Citibank served as administrative agent.